Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Preaxia Health Care Payment Systems (PAXH) Shares Outstanding (Weighted Average) (2019 - 2025)

Preaxia Health Care Payment Systems (PAXH) has disclosed Shares Outstanding (Weighted Average) for 7 consecutive years, with $19.8 million as the latest value for Q3 2025.

  • Quarterly Shares Outstanding (Weighted Average) changed 0.0% to $19.8 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $19.8 million through Aug 2025, changed 0.0% year-over-year, with the annual reading at $19.8 million for FY2025, 0.0% changed from the prior year.
  • Shares Outstanding (Weighted Average) hit $19.8 million in Q3 2025 for Preaxia Health Care Payment Systems, roughly flat from $19.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $19.8 million in Q3 2021 to a low of $19.8 million in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $19.8 million across 5 years, with a median of $19.8 million in 2021.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): increased 0.51% in 2021 and later dropped 0.15% in 2022.
  • Year by year, Shares Outstanding (Weighted Average) stood at $19.8 million in 2021, then changed by 0.0% to $19.8 million in 2022, then changed by 0.0% to $19.8 million in 2023, then changed by 0.0% to $19.8 million in 2024, then changed by 0.0% to $19.8 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for PAXH at $19.8 million in Q3 2025, $19.8 million in Q2 2025, and $19.8 million in Q1 2025.